Kate Bingham, Chair of the Government's Vaccine Taskforce, after starting her Novavax trial at the Royal Free Hospital, north London on October 13, 2020.suggest The University of Oxford and AstraZeneca's COVID-19 vaccine produces an immune response and is safe in older adults.
Older people who took part in the Oxford COVID-19 vaccine trial were less likely to have side effects than younger participants, researchers said. This is positive news because the type of vaccine the group is working on — known as an adenovirus-vector platform — has either not been tested in older people, or when it has been tested, it has shown worse results compared to younger people.Whether the shot is effective at protecting people against COVID-19 remains unknown, but results from Oxford's Phase 3 trials are expected in a matter of weeks.
"I think the reason we are so delighted is that the immune responses look exactly the same, even in those ... over 70 years of age," Pollard said.
good news
'Safe' you say! Should be fascinating in the future when class actions are inevitably launched (cos lawyers right:) & they're told you can't sue the Pharma companies, who will they then focus on. I have a mirror of you need it.
FDA ReviewAndPickwhichIstheBestVaccineByThanksgiving.
horrible
I volunteer na tagaan ug shots. Asa pwd mag adto